Fractional Chief Medical Officer

tranScrip’s Fractional CMO service gives biotech companies immediate access to flexible senior, industry-experienced medical leadership, tailored to the stage of development and therapeutic need.

A
A
Unlike traditional CROs or standalone consultants, tranScrip combines strategic CMO-level oversight with the full depth of its multidisciplinary teams in regulatory, nonclinical, CMC, clinical operational, drug safety, commercial and translational science.

This means companies don’t just get a single expert, but a connected bespoke network – as needed – that can anticipate risks, shape development strategy, and execute solutions seamlessly. The result is flexible, informed leadership, faster decision-making, and the assurance that every critical step is guided by people who have done it before.

What a tranScrip CMO provides

Strategic medical leadership across all stages of development
Access to a network of other key SME personnel
Oversight of product strategy, cross-functional and clinical development plans
Detailed study design(s) through to full protocol development and delivery
Representation in interactions with global health authorities
Leadership of medical affairs strategy and plans
Consulting with broader stakeholders and prospective investors / partners
Strategic development insight for out-licensing options

Why choose a tranScrip CMO

Exceptional Seniority and Credibility

Every tranScrip Fractional CMO is an industry-tested pharmaceutical physician with a track record of guiding programmes through complex development paths.

The Power of a Whole Team, Not One Individual

Your Fractional CMO is backed by tranScrip’s full team of regulatory, nonclinical, clinical operational, commercial and translational experts. This collective strength means you get rapid, authoritative answers across disciplines — not the limits of a single consultant who may be unavailable when you need them most.

Flexible Leadership, Precisely When You Need It

Whether for a critical milestone, investor engagement, programme rescue, or sustained oversight, tranScrip provides senior medical leadership on a fractional, scalable basis — without the cost or commitment of a permanent CMO.

A True Partner in Value Creation

We work as an extension of your team, bringing clarity, confidence, and strategic alignment to maximise the value of your product — and the long-term success of your company.

“tranScrip provided us with a virtual Chief Medical Officer (CMO), and the impact was transformational for Rhino Therapeutics. Their physician integrated seamlessly into our team, providing the strategic clinical leadership we needed at a pivotal stage of our programme. From shaping a clear early-development pathway to guiding the design of our first-in-human strategy, their expertise brought structure, confidence and real momentum to our work.

Importantly, the virtual CMO is backed by tranScrip’s full team of regulatory, nonclinical, clinical operational, commercial and translational experts, meaning we received rapid, authoritative answers across disciplines, rather than the limits of a single consultant who might be unavailable when needed most. The quality of their insights and documentation significantly strengthened our engagement with investors and partners. tranScrip delivered exactly what we needed; experienced, pragmatic leadership that made an immediate and lasting impact.”

Andy Mulvaney

CEO

Rhino Therapeutics

Explore further

Don’t let gaps in medical leadership slow your progress. Speak with us now to see how tranScrip’s Fractional CMO can help drive momentum, transform your journey — from TRANslation to preSCRIPtion.

Get in touch